The and Variants Are Associated with Multiple Sclerosis: A Study on Iranian Population

Overview

Journal Iran J Biotechnol

Specialty Biotechnology

Date 2022 Nov 16

PMID 36381285

Authors

Sevil Babashpour

Mitra Ataei

Ferdous Rastgtar Jazii

Shekoofeh Alaie

Mohammad Hossein Sanati

Affiliations

Soon will be listed here.

Abstract

Background: Studies have shown that MS results from synergism between genetic and environmental factors. As a genetic factor, the variant through the regulatory effect on the expression is involved in the MS development. In addition, vitamin D deficiency through involvement of variant of has shown to play important role in the risk of MS.

Objectives: The aim of this study was to investigate both the and variants with risk of multiple sclerosis (MS) in Iranian population.

Materials And Methods: The and variants were genotyped in 82 Iranian Relapsing-Remitting Multiple Sclerosis (RRMS) patients and 100 matched healthy controls, using the PCR-RFLP method. The genotype and allele frequencies were calculated and statistically analyzed.

Results: A significant difference was found in the allele distribution for the both and variants, such that the A allele of and the C allele of were found to be more frequent in MS patients than in the healthy controls (p-value: 0.009, OR: 2.264, 95% CI: 1.211-4.231 and p-value: 0.028 OR: 1.594, 95% CI: 1.052-2.415), respectively.

Conclusions: The present research results provide further evidence on the association of the two variants of the and of the gene with MS etiology and an increased risk of MS in Iranian RRMS patients. However, further large-scale investigations in various ethnicities and in the functional genomics level are demanded to confirm our findings.

References

Pierrot-Deseilligny C, Souberbielle J . Vitamin D and multiple sclerosis: An update. Mult Scler Relat Disord. 2017; 14:35-45. DOI: 10.1016/j.msard.2017.03.014. View

Barcellos L, Sawcer S, Ramsay P, Baranzini S, Thomson G, Briggs F . Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet. 2006; 15(18):2813-24. DOI: 10.1093/hmg/ddl223. View

Ramasamy A, Trabzuni D, Forabosco P, Smith C, Walker R, Dillman A . Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme in multiple sclerosis. Mult Scler Relat Disord. 2015; 3(2):211-219. PMC: 4278441. DOI: 10.1016/j.msard.2013.08.009. View

Yu S, Li X, Wang Y, Mao Z, Wang C, Ba Y . Maternal transmission disequilibrium of rs2248359 in type 2 diabetes mellitus families and its association with vitamin D level in offspring. Sci Rep. 2018; 8(1):1345. PMC: 5778029. DOI: 10.1038/s41598-018-19838-5. View

Compston A, Coles A . Multiple sclerosis. Lancet. 2008; 372(9648):1502-17. DOI: 10.1016/S0140-6736(08)61620-7. View

Sadeghi H, Taheri M, Sajadi E, Movafagh A, Jang S, Sayad A . VDR and CYP24A1 Expression Analysis in Iranian Relapsing-Remitting Multiple Sclerosis Patients. Cell J. 2017; 19(3):352-360. PMC: 5570401. DOI: 10.22074/cellj.2017.4192. View

Sawcer S, Hellenthal G, Pirinen M, Spencer C, Patsopoulos N, Moutsianas L . Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476(7359):214-9. PMC: 3182531. DOI: 10.1038/nature10251. View

Boonstra A, Barrat F, Crain C, Heath V, Savelkoul H, OGarra A . 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001; 167(9):4974-80. DOI: 10.4049/jimmunol.167.9.4974. View

Ramagopalan S, McMahon R, Dyment D, Sadovnick A, Ebers G, Wittkowski K . An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene. BMC Med Genet. 2009; 10:10. PMC: 2669470. DOI: 10.1186/1471-2350-10-10. View

10.

Koch-Henriksen N, Soelberg Sorensen P . The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010; 9(5):520-32. DOI: 10.1016/S1474-4422(10)70064-8. View

11.

Hejgaard Laursen J, Bach Sondergaard H, Soelberg Sorensen P, Sellebjerg F, Oturai A . Association between age at onset of multiple sclerosis and vitamin D level-related factors. Neurology. 2015; 86(1):88-93. DOI: 10.1212/WNL.0000000000002075. View

12.

Eskandarieh S, Heydarpour P, Elhami S, Sahraian M . Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran. Iran J Public Health. 2017; 46(5):699-704. PMC: 5442284. View

13.

Zhuang J, Huang Z, Zhao G, Yu H, Li Z, Wu Z . Variants of CYP27B1 are associated with both multiple sclerosis and neuromyelitis optica patients in Han Chinese population. Gene. 2014; 557(2):236-9. DOI: 10.1016/j.gene.2014.12.045. View

14.

Hallau J, Hamann L, Schumann R, Worm M, Heine G . A Promoter Polymorphism of the Vitamin D Metabolism Gene Cyp24a1 is Associated with Severe Atopic Dermatitis in Adults. Acta Derm Venereol. 2015; 96(2):169-72. DOI: 10.2340/00015555-2226. View

15.

Smagina I, Lunev K, Elchaninova S . [Association between vitamin D status and CYP27b1 and CYP24A1 gene polymorphisms in patients with multiple sclerosis in the Altai region]. Zh Nevrol Psikhiatr Im S S Korsakova. 2020; 120(7. Vyp. 2):61-66. DOI: 10.17116/jnevro202012007261. View

16.

Beecham A, Patsopoulos N, Xifara D, Davis M, Kemppinen A, Cotsapas C . Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013; 45(11):1353-60. PMC: 3832895. DOI: 10.1038/ng.2770. View

17.

Jones G, Prosser D, Kaufmann M . 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys. 2011; 523(1):9-18. DOI: 10.1016/j.abb.2011.11.003. View

18.

Akkad D, Olischewsky A, Reiner F, Hellwig K, Esser S, Epplen J . Combinations of susceptibility genes are associated with higher risk for multiple sclerosis and imply disease course specificity. PLoS One. 2015; 10(5):e0127632. PMC: 4444291. DOI: 10.1371/journal.pone.0127632. View

19.

Ramagopalan S, Maugeri N, Handunnetthi L, Lincoln M, Orton S, Dyment D . Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009; 5(2):e1000369. PMC: 2627899. DOI: 10.1371/journal.pgen.1000369. View

20.

Misicka E, Davis M, Kim W, Brugger S, Beales J, Loomis S . A higher burden of multiple sclerosis genetic risk confers an earlier onset. Mult Scler. 2021; 28(8):1189-1197. DOI: 10.1177/13524585211053155. View